; DOV Pharmaceutical s principal activities are to discover, in-license, develop and commercialize novel drug candidates for central nervous system, cardiovascular and urological disorders. The group has six product candidates in clinical trails. The products of the group include Indiplon, Ocinaplon, Bicifadine and Diltiazem. These products will be used for the treatment of insomnia, anxiety...